The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression | Revista de Psiquiatría y Salud Mental (English Edition)

array:22 ["pii" => "S217350502100056X" "issn" => "21735050" "doi" => "10.1016/j.rpsmen.2021.11.003" "estado" => "S300" "fechaPublicacion" => "2021-10-01" "aid" => "514" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Psiquiatr Salud Ment. 2021;14:212-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S2173505021000571" "issn" => "21735050" "doi" => "10.1016/j.rpsmen.2020.12.002" "estado" => "S300" "fechaPublicacion" => "2021-10-01" "aid" => "522" "copyright" => "SEP y SEPB" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Psiquiatr Salud Ment. 2021;14:218-26" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Obsessive–compulsive symptoms in anxiety and depressive disorders: Influence of recent and/or traumatic life events" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "218" "paginaFinal" => "226" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Síntomas obsesivo-compulsivos en los trastornos depresivos y de ansiedad: la influencia de eventos recientes y/o experiencias traumáticas" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1686 "Ancho" => 2500 "Tamanyo" => 131585 ] ] "descripcion" => array:1 [ "en" => "Mean (± S.D.) HARS, HDRS-17 and OCI-R scores (mean, SD) at baseline and follow-up evaluation. Abbreviations: Hamilton Anxiety Rating Scale (HARS). Hamilton Depression Rating Scale 17 items (HRSD-17); Revised Inventory of Obsessions and Compulsions (OCI-R); 1 (Baseline evaluation). 2 (Follow-up Evaluation)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Arantxa Orozco, Narcís Cardoner, Cristina F. Aragón, Salvador Ruiz-Murugarren, María Vicens, Miguel Ángel Álvarez-Mon, Guillermo Lahera" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Arantxa" "apellidos" => "Orozco" ] 1 => array:2 [ "nombre" => "Narcís" "apellidos" => "Cardoner" ] 2 => array:2 [ "nombre" => "Cristina F." "apellidos" => "Aragón" ] 3 => array:2 [ "nombre" => "Salvador" "apellidos" => "Ruiz-Murugarren" ] 4 => array:2 [ "nombre" => "María" "apellidos" => "Vicens" ] 5 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Álvarez-Mon" ] 6 => array:2 [ "nombre" => "Guillermo" "apellidos" => "Lahera" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173505021000571?idApp=UINPBA00004N" "url" => "/21735050/0000001400000004/v1_202112011640/S2173505021000571/v1_202112011640/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173505021000509" "issn" => "21735050" "doi" => "10.1016/j.rpsmen.2019.10.005" "estado" => "S300" "fechaPublicacion" => "2021-10-01" "aid" => "459" "copyright" => "SEP y SEPB" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Psiquiatr Salud Ment. 2021;14:202-11" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Sensitivity and specificity of DSM-5 diagnostic criteria for autism spectrum disorder in a child and adolescent sample" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "202" "paginaFinal" => "211" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sensibilidad y especificidad de los criterios diagnósticos DSM-5 en el trastorno del espectro autista en una muestra de niños y adolescentes españoles" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana Blázquez Hinojosa, Luisa Lázaro Garcia, Olga Puig Navarro, Eva Varela Bondelle, Rosa Calvo Escalona" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Blázquez Hinojosa" ] 1 => array:2 [ "nombre" => "Luisa" "apellidos" => "Lázaro Garcia" ] 2 => array:2 [ "nombre" => "Olga" "apellidos" => "Puig Navarro" ] 3 => array:2 [ "nombre" => "Eva" "apellidos" => "Varela Bondelle" ] 4 => array:2 [ "nombre" => "Rosa" "apellidos" => "Calvo Escalona" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1888989119300990" "doi" => "10.1016/j.rpsm.2019.10.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1888989119300990?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173505021000509?idApp=UINPBA00004N" "url" => "/21735050/0000001400000004/v1_202112011640/S2173505021000509/v1_202112011640/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "Brief report" "titulo" => "The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "212" "paginaFinal" => "217" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Victor Augusto Rodovalho Fava, Luciana Maria Sarin, Ana Cecília Lucchese, Lorena Del Sant, Eduardo Magalhães, Rodrigo Simonini Delfino, Marco Aurélio Tuena, Carolina Nakahira, Andrea Parolin Jackowski, Guilherme Abdo, Juliana Surjan, Matheus Steiglich, Matheus Ghossain Barbosa, José Alberto Del Porto, Acioly Luiz Tavares Lacerda, Hugo Cogo-Moreira" "autores" => array:16 [ 0 => array:3 [ "nombre" => "Victor Augusto Rodovalho" "apellidos" => "Fava" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Luciana Maria" "apellidos" => "Sarin" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Ana Cecília" "apellidos" => "Lucchese" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Lorena" "apellidos" => "Del Sant" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 4 => array:3 [ "nombre" => "Eduardo" "apellidos" => "Magalhães" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "Rodrigo Simonini" "apellidos" => "Delfino" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 6 => array:3 [ "nombre" => "Marco Aurélio" "apellidos" => "Tuena" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "Carolina" "apellidos" => "Nakahira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 8 => array:3 [ "nombre" => "Andrea Parolin" "apellidos" => "Jackowski" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 9 => array:3 [ "nombre" => "Guilherme" "apellidos" => "Abdo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 10 => array:3 [ "nombre" => "Juliana" "apellidos" => "Surjan" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 11 => array:3 [ "nombre" => "Matheus" "apellidos" => "Steiglich" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 12 => array:3 [ "nombre" => "Matheus Ghossain" "apellidos" => "Barbosa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 13 => array:3 [ "nombre" => "José Alberto Del" "apellidos" => "Porto" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 14 => array:3 [ "nombre" => "Acioly Luiz Tavares" "apellidos" => "Lacerda" "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] 2 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] 3 => array:2 [ "etiqueta" => "1" "identificador" => "fn0005" ] ] ] 15 => array:4 [ "nombre" => "Hugo" "apellidos" => "Cogo-Moreira" "email" => array:1 [ 0 => "hugocogo@hku.hk" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "e" "identificador" => "aff0025" ] 2 => array:2 [ "etiqueta" => "1" "identificador" => "fn0005" ] 3 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro Alfa de Humanização, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "PRODAF – Programa de Transtornos Afetivos, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "LiNC – Laboratory of Integrative Neuroscience, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "School of Public Health, University of Hong Kong, Hong Kong, SAR, China" "etiqueta" => "e" "identificador" => "aff0025" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Probabilidad de respuesta tras cada inyección subcutánea de esketamina en la depresión resistente al tratamiento" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 800 "Ancho" => 1667 "Tamanyo" => 49889 ] ] "descripcion" => array:1 [ "en" => "Hidden Markov model (HMM): observed variables and their corresponding latent class variables as they transition along the doses. The HMM generated a latent class variable for each time point after doses 1–4 (lat1, lat2, lat3, and lat4). Each latent class variable captured the unobserved features that were present at their respective time point and are correlated with the observed variable at that time point (obs1, obs2, obs3, and obs4). An observed variable and its corresponding latent class variable were either a “responder” or a “non-responder”. Each latent class variable transitioned into a subsequent one after the respective esketamine dose administration (e.g., lat1 transitioned into lat2 after dose 1)." ] ] ] "textoCompleto" => "IntroductionThe treatment of patients with bipolar depression or major depressive disorder may be very challenging, as pharmacological interventions are ineffective in a significant portion of cases.<a class="elsevierStyleCrossRef" href="#bib0135">1</a> Patients who do not achieve remission after two or more treatments with an adequate dose of antidepressant for an adequate duration are considered to have treatment-resistant depression (TRD).<a class="elsevierStyleCrossRef" href="#bib0140">2</a> Ketamine and esketamine have been shown to have a robust antidepressant effect in such cases and have been considered to be a breakthrough in this context.<a class="elsevierStyleCrossRefs" href="#bib0145">3–5</a> To date, there are no clinical practice guidelines recommending the use of ketamine or esketamine for depressive disorders.<a class="elsevierStyleCrossRef" href="#bib0150">4</a>Ketamine is an N-methyl-d-aspartate (NMDA) receptor antagonist. Its antidepressant activity is attributed to several mechanisms that converge into the generation of synaptic plasticity and potentiating of excitatory neurotransmission.<a class="elsevierStyleCrossRef" href="#bib0160">6</a> Most hypotheses consider the blockage of NMDA receptors to be essential to the antidepressant effect, but there is also research showing that ketamine's metabolites may independently exert it.<a class="elsevierStyleCrossRef" href="#bib0165">7</a> At the cellular level, ketamine leads to the activation of post synaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs), that triggers intracellular brain-derived neurotrophic factor (BDNF) release and the subsequent activation of the mechanistic target of rapamycin complex 1 (mTORC1).<a class="elsevierStyleCrossRef" href="#bib0170">8</a>Ketamine is a racemate, comprising the S-(1)-ketamine enantiomer (esketamine) and the R-(2)-ketamine enantiomer (arketamine). It has been demonstrated that esketamine is non-inferior compared to ketamine for patients with TRD.<a class="elsevierStyleCrossRef" href="#bib0175">9</a> Esketamine has also been related to a better safety profile.<a class="elsevierStyleCrossRef" href="#bib0180">10</a> It can be administrated through several routes, as following: oral, subcutaneous (SC), intranasal, intramuscular, intravenous (IV).<a class="elsevierStyleCrossRef" href="#bib0185">11</a> Data with respect to SC administration of esketamine are limited.<a class="elsevierStyleCrossRef" href="#bib0190">12</a> Although, it has been found that SC route appears to be more affordable and to have fewer collateral effects than the IV route, while showing comparable efficacy in the treatment of TRD.<a class="elsevierStyleCrossRef" href="#bib0195">13</a>The administration of multiple doses of esketamine has shown efficacy for TRD, as demonstrated by a large number of published phase 2 and phase 3 studies.<a class="elsevierStyleCrossRefs" href="#bib0180">10,14–17</a> Nevertheless, these trials did not provide a clear idea regarding the probability that a “non-responder” will become a “responder” (and vice-versa) after each esketamine infusion. Generally, they reported an average odds ratio, calculated based on a longitudinal design and not on the individual transitions. Understanding the individual transitions should help us answer the following critical questions: if a patient is a “responder” to esketamine injection, what is the probability of maintaining the same response status after the second injection? Similarly, if a patient is a “non-responder” at first, what is the probability of becoming a “responder” after a subsequent dose? In the case of multiple esketamine injections, being a “responder” may impact the response status of the subsequent injection. Hidden Markov model (HMM) is applicable to the case of multiple esketamine injections as it calculates the probability of changing from one response status to another, while considering the previous status with each transition.The current naturalistic cohort study examines the probability of transitioning from being a “non-responder” to becoming a “responder” after each SC administration of esketamine, following four injections from a series of six in 70 patients with TRD.Material and methodsParticipants and proceduresThe data in this study originated from a retrospective analysis of a case series of 70 patients with TRD, who were referred by their treating psychiatrist to the esketamine clinic at the Department of Psychiatry of the Federal University of São Paulo, between April 2017 and December 2018.Patients signed and dated a written informed consent document, in support of their participation in the study, and were aware they were not participating in a research protocol, but in an academic assistance program. The study was approved by the Federal University of São Paulo Ethics Committee (No. 434/2018).Inclusion criteria were as follows: current diagnosis of either major depressive disorder or bipolar depression according to DSM-IV as assessed with the Mini-International Neuropsychiatric Interview-Plus (MINI-Plus) 5.0; prior history of non-response to at least two antidepressants or approved drugs for bipolar depression, used in an effective dose for at least 6 weeks; Montgomery-Åsberg Depression Rating Scale (MADRS) score of ≥25; age of 15 years or more. Exclusion criteria were as follows: history of hypersensitivity and/or allergy to ketamine/esketamine; diagnosis of ketamine/esketamine abuse or dependence; uncontrolled hypertension; pregnancy.Participants were kept on stable doses of medications during the esketamine treatment. Each participant received up to six weekly SC injections of esketamine in the abdomen, at a dose of 0.5–1.0mg/kg. A response was defined as at least 50% decrease from baseline in the MADRS total score, 24h after dose administration.<a class="elsevierStyleCrossRef" href="#bib0220">18</a> This definition was used to describe the patients as “responder” and “non-responder”. Patients, who did not become a “responder” within 24h of receiving a dose, received an increase of 0.25mg/kg in the subsequent dose, up to 1.0mg/kg.Statistical analysisWe used HMM to analyze the probability of a patient to become a “responder” or “non-responder” throughout four esketamine doses. This method permits the analysis of a system whose actual state is not yet known, but will be randomly originated from a certain future event.<a class="elsevierStyleCrossRef" href="#bib0225">19</a> In this study, esketamine injection was the event and it generated two possible observed outcomes: “responder” and “non-responder”. As a latent transition analysis, HMM can describe the underlying population behavior based on a set of observed variables. It identifies latent class variables, which construct common patterns and behaviors from the whole population at the time of each of observation. HMM analyzes the way individuals transition longitudinally from one latent class to another,<a class="elsevierStyleCrossRef" href="#bib0230">20</a> as illustrated in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>.<elsevierMultimedia ident="fig0005"></elsevierMultimedia>Using Mplus 8 software,<a class="elsevierStyleCrossRef" href="#bib0235">21</a> two HMMs were constructed. In one model, the transition matrices (latent state intercepts and autoregressive paths) were kept equal across the doses (Model 1). The other model had no constraints (Model 2). To calculate the difference in fit between the two models and to determine which model is more representative of the data, we applied scaled loglikelihood-ratio tests.Additionally, we evaluated whether having major depressive disorder rather than bipolar depression would impact the latent response status across the doses of esketamine. Considering the reduced sample size and the number of parameters to estimate (one for each wave of assessment under HMM), the following constraints were imposed: we assumed that the probability of being “responder” and “non-responder” in every wave of assessment would be constant between both groups (i.e., having major depressive disorder rather than bipolar depression). Therefore, the hypothesis underlying these constraints is that having major depressive disorder would cause the same impact across the four injections, in terms of modifying the probability of response.Results<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> shows the demographic and the clinical characteristics of the total cohort. This naturalistic cohort is representative of patients with TRD who are referred to off-label esketamine treatment. Most patients had severe TRD (mean Madsley Staging Method total score >11) and 81.42% of them had at least one clinical comorbidity.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia><a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a> illustrates the number of patients that received each dose of esketamine and the corresponding number of patients that were evaluated 24h after that dose. We observed that after dose 1, the proportion of patients responding to esketamine was 37.70%. After dose 4, it was 62.50%.<elsevierMultimedia ident="fig0010"></elsevierMultimedia>The constrained HMM (model 1) was more representative of the observed data than model 2 (freed HMM): Log likelihood: −137.84; test=χ2 (df) = 3.04, p-value=1.00. In model 1, a total of 16 patterns of the latent class variables were found across the doses. The most frequent patterns were: (a) “non-responder” across the four time points (46.44%), defined as “always non-responder” and (b) “responder” across the four time points (15.32%), defined as “always responder”. Other prevalent latent patterns were: non-responder-responder-responder-responder (12.85%); non-responder-non-responder-responder-responder (11.18%) and non-responder-non-responder-non-responder-responder (9.72%).According to model 1, the probability of a patient that was a “non-responder” after dose 1 to become a “responder” following dose 2 was 17.30%, and the probability that this patient remains a “non-responder” following dose 2 was 82.70%. The probability of a patient that was a “responder” after dose 1 remains a “responder” following dose 2 was 95%, whereas the probability that this patient will move back to “non-responder” was 5%. Since model 1 has equal transitioning matrices, the same probabilities were obtained across the other doses.We tested the hypothesis that patients with major depressive disorder would have a different probability of response across the doses when compared to bipolar depressive patients. Lack of evidence was found that unipolar depression would predict more responders (odds ratio=0.57, p-value=0.18).DiscussionTo our knowledge, this is the first study that used HMM to estimate the real-world probability that TRD patients respond throughout multiple SC esketamine injections. As estimated by the best-fitted model, the patterns of “always non-responder” and “always responder” were the most frequent latent behaviors across the four doses; however, the “always non-responder” pattern was three times more frequent than the “always responder” pattern.The model also found that the probability of being a “stayer” (maintaining the same latent response status of either “responder” or “non-responder”) from one injection to the subsequent one was higher than the probability of being of a “mover” (transitioning to a different latent status at any point). Accordingly, it appears to be more likely to maintain the latent status “responder” than to become a “responder”. Yet, the probability of moving from a “non-responder” to a “responder” after a dose was 17.30%. This probability is conditioned by the latent status obtained at the time before and, by constraints of the model, is held equal across the other time points.Intranasal esketamine has been approved for the treatment of TRD, in conjunction with oral antidepressants.<a class="elsevierStyleCrossRef" href="#bib0240">22</a> Even though the current study explored the SC route of administration, it provides information about repeated doses of esketamine in the clinical practice. We found no distinction in the probability of response to esketamine between unipolar and bipolar patients across the doses. On the contrary, a meta-analysis has shown that ketamine's antidepressant effect may extend over a longer period in the case of major depressive disorder compared to bipolar depression.<a class="elsevierStyleCrossRef" href="#bib0245">23</a> Nevertheless, the study considered only trials with a single ketamine infusion. In clinical trials with multiple doses of ketamine, the number of patients who achieve response appears to increase in the case of unipolar depression<a class="elsevierStyleCrossRefs" href="#bib0250">24,25</a> and also in the case of bipolar depression.<a class="elsevierStyleCrossRef" href="#bib0260">26</a>Our findings should be looked at with caution because the study has some limitations. The absence of a control group and randomization, which are inherent to a real-world analysis, limits the internal validity of the study. Patients came from the same academic site, and the number of patients enrolled in the study was somewhat limited. In addition, some of the patients missed one or more evaluations, which is common in a real-world study. The number of patients has also limited the analysis of whether having major depression disorder would be a modifier of the probability of response to esketamine compared to having bipolar depression. Moreover, participants kept their existing psychotropic medications during the esketamine treatment, which may have influenced the results. Furthermore, we did not consider the increase in the esketamine dose as a variable and the response was evaluated over a short period of time.In conclusion, our results provide details about the transition dynamics of response to multiple SC doses of esketamine in the treatment of TRD. Considering four SC esketamine injections, a patient with TRD, who had been “non-responder” after a dose, still had a chance (17.30%) to become a “responder” following the subsequent dose. Additional research with a larger sample size a randomized placebo-controlled design is needed to further evaluate the response to multiple doses of esketamine administered through the SC route.FundingThis work was supported in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001.Conflict of interestThe authors declare the following potential conflicts of interest:Dr. Sarin reports personal fees from Daiichi Sankyo Brasil, Lundbeck Brasil, Pfizer, and Janssen and non-financial support from Takeda Brasil, Moksha8 Brasil, and Torrent Pharma, outside the submitted work. Dr. Magalhães reports non-financial support from Torrent Pharma and Hypera Pharma, outside the submitted work. Dr. Nakahira reports non-financial support from Eurofarma, Cristália, and Sanofi, outside the submitted work. Dr. Lacerda has received consulting fees from Janssen Pharmaceutical, Daiichi Sankyo Brasil, Cristalia Produtos Químicos e Farmacêuticos, Pfizer, Mantecorp Indústria Química e Farmacêutica, Libbs Farmacêutica, and Sanofi-Aventis over the last 24 months and has received research fees from Janssen Pharmaceutical, Eli Lilly, H. Lundbeck A/S, Servier Laboratories, Hoffman-La Roche, and Forum Pharmaceuticals, not related to the submitted manuscript. None of the remaining authors have any potential conflicts to disclose." "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres1619145" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1446174" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1619146" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1446175" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and methods" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Participants and procedures" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Statistical analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0025" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0030" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0035" "titulo" => "Funding" ] 9 => array:2 [ "identificador" => "sec0040" "titulo" => "Conflict of interest" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-06-17" "fechaAceptado" => "2020-10-05" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1446174" "palabras" => array:5 [ 0 => "Esketamine" 1 => "Latent transition analysis" 2 => "Treatment-resistant depression" 3 => "Bipolar depression" 4 => "Treatment response" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1446175" "palabras" => array:5 [ 0 => "Esketamina" 1 => "Análisis de transición latente" 2 => "Depresión resistente al tratamiento" 3 => "Depresión bipolar" 4 => "Respuesta al tratamiento" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "IntroductionThe administration of multiple esketamine doses has shown efficacy for unipolar and bipolar treatment-resistant depression (TRD). Nevertheless, the probability of responding or not after each dose in the real-world remains unknown. This study aimed to estimate it throughout four doses of esketamine, administrated via subcutaneous (SC). Material and methodsWe conducted a retrospective analysis of a case series of 70 patients with TRD who received treatment from the esketamine assistance program at Federal University of Sao Paulo, between April 2017 and December 2018. The SC injections were administrated weekly at a dose of 0.5–1.0mg/kg, in conjunction with patients’ psychotropic drugs. Response was defined as a decrease of at least 50% in the Montgomery-Åsberg Depression Rating Scale between baseline and 24h after dose. We used hidden Markov modeling in order to estimate de probability of response after each esketamine injection. ResultsThe probability of a patient that was a “non-responder” to become a “responder” following a SC injection of esketamine was 17.30% and the probability that this patient remains a “non-responder” was 82.70%. The probability of a patient that was a “responder” to remain as a “responder” was 95%. ConclusionsPatients with TRD who had not responded after the first dose of esketamine, still had a chance of responding after the subsequent dose administrated via SC." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "IntroducciónLa administración de dosis múltiples de esketamina ha demostrado su eficacia para el tratamiento de la depresión unipolar y bipolar resistente al tratamiento (TRD). Sin embargo, sigue siendo una incógnita la probabilidad de responder o no tras cada dosis en el mundo real. El objetivo de este estudio fue calcular dicha probabilidad durante la administración vía subcutánea (SC) de cuatro dosis de esketamina. Material y métodosRealizamos un análisis retrospectivo de una serie de casos de 70 pacientes con TRD, que recibieron tratamiento a través del programa de asistencia con esketamina en la Universidad Federal University de Sao Paulo, entre abril de 2017 y diciembre de 2018. Las inyecciones SC se administraron semanalmente, a dosis de 0,5-1mg/kg, junto con los medicamentos psicotrópicos de los pacientes. Se definió la respuesta como una reducción de al menos el 50% en la Escala de Calificación de la Depresión de Montgomery-Åsberg entre el valor basal y las 24 horas posteriores a la administración de la dosis. Utilizamos el modelo oculto de Markov para calcular la probabilidad de respuesta tras cada inyección de esketamina. ResultadosLa probabilidad de que un paciente que fuera «no respondedor» se convirtiera en «respondedor», tras una inyección SC de esketamina fue del 17,3%, y la probabilidad de que este paciente siguiera siendo «no respondedor» fue del 82,7%. La probabilidad de que un paciente que fuera «respondedor» lo siguiera siendo fue del 95%. ConclusionesLos pacientes con TRD que no han respondido a la primera dosis de esketamina, tienen probabilidad de respuesta tras la administración de las siguientes dosis por vía SC." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:3 [ "etiqueta" => "1" "nota" => "Acioly L.T. Lacerda and Hugo Cogo-Moreira should be considered joint senior authors." "identificador" => "fn0005" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 800 "Ancho" => 1667 "Tamanyo" => 49889 ] ] "descripcion" => array:1 [ "en" => "Hidden Markov model (HMM): observed variables and their corresponding latent class variables as they transition along the doses. The HMM generated a latent class variable for each time point after doses 1–4 (lat1, lat2, lat3, and lat4). Each latent class variable captured the unobserved features that were present at their respective time point and are correlated with the observed variable at that time point (obs1, obs2, obs3, and obs4). An observed variable and its corresponding latent class variable were either a “responder” or a “non-responder”. Each latent class variable transitioned into a subsequent one after the respective esketamine dose administration (e.g., lat1 transitioned into lat2 after dose 1)." ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 380 "Ancho" => 2500 "Tamanyo" => 80966 ] ] "descripcion" => array:1 [ "en" => "The number of patients receiving doses 1–4 and the number of evaluated patients 24h after the respective dose." ] ] 2 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "SD: standard deviation; MDD: Major Depressive Disorder; BD: Bipolar Disorder; MADRS: Montgomery–Åsberg Depression Rating Scale; MSM: Maudsley Staging Method; BMI: Body Mass Index. n; %" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Variables \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Value \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">40.31<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> (SD=12.623) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sex</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 (35.7%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">45 (64.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Education</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">College graduate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">42 (60.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Incomplete college graduation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 (17.1%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8–11 years of education \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 (20.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5–8 years of education \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 (2.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Occupational status</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Employed \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16 (22.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Unemployed \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">13 (18.6%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Medical leave \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">22 (31.4%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Retired \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 (10.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Student \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 (12.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Informal worker \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 (4.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Diagnosis</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MDD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">39 (55.7%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">31 (44.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Baseline</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MADRS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">33.6<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> (SD=6.321) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MSM \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11.09<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> (SD=2.034) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Anxiety disorder \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">31 (44.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Prior psychiatric hospitalization \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 (41.1%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Prior suicide history \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 (41.1%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BMI \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29.1<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> (SD=7.456) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Obesity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 (35.7%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 (17.1%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2759137.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "Mean value." ] ] ] "descripcion" => array:1 [ "en" => "Patient demographics and clinical characteristics." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:26 [ 0 => array:3 [ "identificador" => "bib0135" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacological approaches to the challenge of treatment-resistant depression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.F. Ionescu" 1 => "J.F. Rosenbaum" 2 => "J.E. Alpert" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Dialog Clin Neurosci" "fecha" => "2015" "volumen" => "17" "paginaInicial" => "111" "paginaFinal" => "126" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0140" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.S. McIntyre" 1 => "M.J. Filteau" 2 => "L. Martin" 3 => "S. Patry" 4 => "A. Carvalho" 5 => "D.S. Cha" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jad.2013.10.043" "Revista" => array:6 [ "tituloSerie" => "J Affect Disord" "fecha" => "2014" "volumen" => "156" "paginaInicial" => "1" "paginaFinal" => "7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24314926" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0145" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ketamine and beyond: investigations into the potential of glutamatergic agents to treat depression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.S. Lener" 1 => "B. Kadriu" 2 => "C.A. Zarate" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40265-017-0702-8" "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2017" "volumen" => "77" "paginaInicial" => "381" "paginaFinal" => "401" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28194724" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0150" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Á. López-Díaz" 1 => "M. Murillo-Izquierdo" 2 => "E. Moreno-Mellado" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1192/bjp.2019.102" "Revista" => array:6 [ "tituloSerie" => "Br J Psychiatry" "fecha" => "2019" "volumen" => "215" "paginaInicial" => "447" "paginaFinal" => "448" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31030677" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0155" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eficacia y seguridad de la ketamina en depresión bipolar: una revisión sistemática" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Alberich" 1 => "M. Martínez-Cengotitabengoa" 2 => "P. López" 3 => "I. Zorrilla" 4 => "N. Núñez" 5 => "E. Vieta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rpsm.2016.05.005" "Revista" => array:6 [ "tituloSerie" => "Rev Psiquiatr Salud Ment" "fecha" => "2017" "volumen" => "10" "paginaInicial" => "104" "paginaFinal" => "112" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27387226" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0160" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms of ketamine action as an antidepressant" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Zanos" 1 => "T.D. Gould" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/mp.2017.255" "Revista" => array:6 [ "tituloSerie" => "Mol Psychiatry" "fecha" => "2018" "volumen" => "23" "paginaInicial" => "801" "paginaFinal" => "811" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29532791" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0165" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "NMDAR inhibition-independent antidepressant actions of ketamine metabolites" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Zanos" 1 => "R. Moaddel" 2 => "P.J. Morris" 3 => "P. Georgiou" 4 => "J. Fischell" 5 => "G.I. Elmer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nature" "fecha" => "2016" "volumen" => "533" "paginaInicial" => "481" "paginaFinal" => "486" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0170" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W. Zhou" 1 => "N. Wang" 2 => "C. Yang" 3 => "X.M. Li" 4 => "Z.Q. Zhou" 5 => "J.J. Yang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.eurpsy.2013.10.005" "Revista" => array:6 [ "tituloSerie" => "Eur Psychiatry" "fecha" => "2014" "volumen" => "29" "paginaInicial" => "419" "paginaFinal" => "423" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24321772" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0175" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F.S. Correia-Melo" 1 => "G.C. Leal" 2 => "F. Vieira" 3 => "A.P. Jesus-Nunes" 4 => "R.P. Mello" 5 => "G. Magnavita" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jad.2019.11.086" "Revista" => array:6 [ "tituloSerie" => "J Affect Disord" "fecha" => "2020" "volumen" => "264" "paginaInicial" => "527" "paginaFinal" => "534" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31786030" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0180" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Popova" 1 => "E.J. Daly" 2 => "M. Trivedi" 3 => "K. Cooper" 4 => "R. Lane" 5 => "P. Lim" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Psychiatry" "fecha" => "2019" "volumen" => "176" "paginaInicial" => "428" "paginaFinal" => "438" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0185" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Administration of ketamine for unipolar and bipolar depression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Kraus" 1 => "U. Rabl" 2 => "T. Vanicek" 3 => "L. Carlberg" 4 => "A. Popovic" 5 => "M. Spies" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Int J Psychiatry Clin Pract" "fecha" => "2017" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0190" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A consensus statement on the use of ketamine in the treatment of mood disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Sanacora" 1 => "M.A. Frye" 2 => "W. McDonald" 3 => "S.J. Mathew" 4 => "M.S. Turner" 5 => "A.F. Schatzberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamapsychiatry.2017.0080" "Revista" => array:6 [ "tituloSerie" => "JAMA Psychiatry" "fecha" => "2017" "volumen" => "74" "paginaInicial" => "399" "paginaFinal" => "405" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28249076" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0195" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.K. Loo" 1 => "V. Gálvez" 2 => "E. O’Keefe" 3 => "P.B. Mitchell" 4 => "D. Hadzi-Pavlovic" 5 => "J. Leyden" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/acps.12572" "Revista" => array:6 [ "tituloSerie" => "Acta Psychiatr Scand" "fecha" => "2016" "volumen" => "134" "paginaInicial" => "48" "paginaFinal" => "56" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27028832" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0200" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.B. Singh" 1 => "M. Fedgchin" 2 => "E. Daly" 3 => "L. Xi" 4 => "C. Melman" 5 => "G. De Bruecker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.biopsych.2015.10.018" "Revista" => array:6 [ "tituloSerie" => "Biol Psychiatry" "fecha" => "2016" "volumen" => "80" "paginaInicial" => "424" "paginaFinal" => "431" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26707087" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0205" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.M. Canuso" 1 => "J.B. Singh" 2 => "M. Fedgchin" 3 => "L. Alphs" 4 => "R. Lane" 5 => "P. Lim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1176/appi.ajp.2018.17060720" "Revista" => array:6 [ "tituloSerie" => "Am J Psychiatry" "fecha" => "2018" "volumen" => "175" "paginaInicial" => "620" "paginaFinal" => "630" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29656663" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0210" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.J. Daly" 1 => "J.B. Singh" 2 => "M. Fedgchin" 3 => "K. Cooper" 4 => "P. Lim" 5 => "R.C. Shelton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamapsychiatry.2017.3739" "Revista" => array:6 [ "tituloSerie" => "JAMA Psychiatry" "fecha" => "2018" "volumen" => "75" "paginaInicial" => "139" "paginaFinal" => "148" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29282469" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0215" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.J. Daly" 1 => "M.H. Trivedi" 2 => "A. Janik" 3 => "H. Li" 4 => "Y. Zhang" 5 => "X. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamapsychiatry.2019.1189" "Revista" => array:6 [ "tituloSerie" => "JAMA Psychiatry" "fecha" => "2019" "volumen" => "76" "paginaInicial" => "893" "paginaFinal" => "903" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31166571" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0220" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Report by the ACNP Task Force on response and remission in major depressive disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.J. Rush" 1 => "H.C. Kraemer" 2 => "H.A. Sackeim" 3 => "M. Fava" 4 => "M.H. Trivedi" 5 => "E. Frank" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.npp.1301131" "Revista" => array:6 [ "tituloSerie" => "Neuropsychopharmacology" "fecha" => "2006" "volumen" => "31" "paginaInicial" => "1841" "paginaFinal" => "1853" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16794566" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0225" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "What is a hidden Markov model?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S.R. Eddy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nbt1004-1315" "Revista" => array:6 [ "tituloSerie" => "Nat Biotechnol" "fecha" => "2004" "volumen" => "22" "paginaInicial" => "1315" "paginaFinal" => "1316" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15470472" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0230" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Latent class and latent transition analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.T. Lanza" 1 => "B.P. Flaherty" 2 => "L.M. Collins" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2003" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0235" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mplus user's guide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L.K. Muthén" 1 => "B.O. Muthén" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:2 [ "edicion" => "6th ed." "fecha" => "2011" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0240" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Esketamine is approved in Europe for treating resistant major depressive disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "E. Mahase" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.l6553" "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2019" "volumen" => "367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31748343" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0245" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Romeo" 1 => "W. Choucha" 2 => "P. Fossati" 3 => "J.Y. Rotge" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.psychres.2015.10.032" "Revista" => array:6 [ "tituloSerie" => "Psychiatry Res" "fecha" => "2015" "volumen" => "230" "paginaInicial" => "682" "paginaFinal" => "688" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26548981" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0250" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.R. Shiroma" 1 => "B. Johns" 2 => "M. Kuskowski" 3 => "J. Wels" 4 => "P. Thuras" 5 => "C.S. Albott" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jad.2013.10.036" "Revista" => array:6 [ "tituloSerie" => "J Affect Disord" "fecha" => "2014" "volumen" => "155" "paginaInicial" => "123" "paginaFinal" => "129" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24268616" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0255" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Phillips" 1 => "S. Norris" 2 => "J. Talbot" 3 => "M. Birmingham" 4 => "T. Hatchard" 5 => "A. Ortiz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1176/appi.ajp.2018.18070834" "Revista" => array:6 [ "tituloSerie" => "Am J Psychiatry" "fecha" => "2019" "volumen" => "176" "paginaInicial" => "401" "paginaFinal" => "409" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30922101" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0260" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W. Zheng" 1 => "Y.L. Zhou" 2 => "W.J. Liu" 3 => "C.Y. Wang" 4 => "Y.N. Zhan" 5 => "H.Q. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jpsychires.2018.09.013" "Revista" => array:6 [ "tituloSerie" => "J Psychiatr Res" "fecha" => "2018" "volumen" => "106" "paginaInicial" => "61" "paginaFinal" => "68" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30278319" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735050/0000001400000004/v1_202112011640/S217350502100056X/v1_202112011640/en/main.assets" "Apartado" => array:4 [ "identificador" => "7614" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735050/0000001400000004/v1_202112011640/S217350502100056X/v1_202112011640/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217350502100056X?idApp=UINPBA00004N"]

Statistics

Brief report

The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression

Probabilidad de respuesta tras cada inyección subcutánea de esketamina en la depresión resistente al tratamiento

Victor Augusto Rodovalho Favaa, Luciana Maria Sarina,b, Ana Cecília Lucchesea,b, Lorena Del Santa,b, Eduardo Magalhãesa,b, Rodrigo Simonini Delfinoa,c, Marco Aurélio Tuenaa, Carolina Nakahiraa, Andrea Parolin Jackowskid, Guilherme Abdoa, Juliana Surjana,c, Matheus Steiglicha, Matheus Ghossain Barbosaa, José Alberto Del Portoa,c, Acioly Luiz Tavares Lacerdaa,c,d,1, Hugo Cogo-Moreiraa,e,1,

Corresponding author

hugocogo@hku.hk

Corresponding author.

a Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil

b Centro Alfa de Humanização, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil

c PRODAF – Programa de Transtornos Afetivos, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil

d LiNC – Laboratory of Integrative Neuroscience, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil

e School of Public Health, University of Hong Kong, Hong Kong, SAR, China

Read

906

Times
was read the article

305

Total PDF

601

Total HTML

Share statistics

 array:22 [
  "pii" => "S217350502100056X"
  "issn" => "21735050"
  "doi" => "10.1016/j.rpsmen.2021.11.003"
  "estado" => "S300"
  "fechaPublicacion" => "2021-10-01"
  "aid" => "514"
  "copyrightAnyo" => "2021"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Rev Psiquiatr Salud Ment. 2021;14:212-7"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173505021000571"
    "issn" => "21735050"
    "doi" => "10.1016/j.rpsmen.2020.12.002"
    "estado" => "S300"
    "fechaPublicacion" => "2021-10-01"
    "aid" => "522"
    "copyright" => "SEP y SEPB"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Rev Psiquiatr Salud Ment. 2021;14:218-26"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Obsessive&#8211;compulsive symptoms in anxiety and depressive disorders&#58; Influence of recent and&#47;or traumatic life events"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "218"
          "paginaFinal" => "226"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;ntomas obsesivo-compulsivos en los trastornos depresivos y de ansiedad&#58; la influencia de eventos recientes y&#47;o experiencias traum&#225;ticas"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1686
              "Ancho" => 2500
              "Tamanyo" => 131585
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Mean &#40;&#177; S&#46;D&#46;&#41; HARS&#44; HDRS-17 and OCI-R scores &#40;mean&#44; SD&#41; at baseline and follow-up evaluation&#46; Abbreviations&#58; Hamilton Anxiety Rating Scale &#40;HARS&#41;&#46; Hamilton Depression Rating Scale 17 items &#40;HRSD-17&#41;&#59; Revised Inventory of Obsessions and Compulsions &#40;OCI-R&#41;&#59; 1 &#40;Baseline evaluation&#41;&#46; 2 &#40;Follow-up Evaluation&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Arantxa Orozco, Narc&#237;s Cardoner, Cristina F&#46; Arag&#243;n, Salvador Ruiz-Murugarren, Mar&#237;a Vicens, Miguel &#193;ngel &#193;lvarez-Mon, Guillermo Lahera"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Arantxa"
              "apellidos" => "Orozco"
            ]
            1 => array:2 [
              "nombre" => "Narc&#237;s"
              "apellidos" => "Cardoner"
            ]
            2 => array:2 [
              "nombre" => "Cristina F&#46;"
              "apellidos" => "Arag&#243;n"
            ]
            3 => array:2 [
              "nombre" => "Salvador"
              "apellidos" => "Ruiz-Murugarren"
            ]
            4 => array:2 [
              "nombre" => "Mar&#237;a"
              "apellidos" => "Vicens"
            ]
            5 => array:2 [
              "nombre" => "Miguel &#193;ngel"
              "apellidos" => "&#193;lvarez-Mon"
            ]
            6 => array:2 [
              "nombre" => "Guillermo"
              "apellidos" => "Lahera"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173505021000571?idApp=UINPBA00004N"
    "url" => "/21735050/0000001400000004/v1_202112011640/S2173505021000571/v1_202112011640/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2173505021000509"
    "issn" => "21735050"
    "doi" => "10.1016/j.rpsmen.2019.10.005"
    "estado" => "S300"
    "fechaPublicacion" => "2021-10-01"
    "aid" => "459"
    "copyright" => "SEP y SEPB"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Rev Psiquiatr Salud Ment. 2021;14:202-11"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Sensitivity and specificity of DSM-5 diagnostic criteria for autism spectrum disorder in a child and adolescent sample"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "202"
          "paginaFinal" => "211"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Sensibilidad y especificidad de los criterios diagn&#243;sticos DSM-5 en el trastorno del espectro autista en una muestra de ni&#241;os y adolescentes espa&#241;oles"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ana Bl&#225;zquez Hinojosa, Luisa L&#225;zaro Garcia, Olga Puig Navarro, Eva Varela Bondelle, Rosa Calvo Escalona"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Bl&#225;zquez Hinojosa"
            ]
            1 => array:2 [
              "nombre" => "Luisa"
              "apellidos" => "L&#225;zaro Garcia"
            ]
            2 => array:2 [
              "nombre" => "Olga"
              "apellidos" => "Puig Navarro"
            ]
            3 => array:2 [
              "nombre" => "Eva"
              "apellidos" => "Varela Bondelle"
            ]
            4 => array:2 [
              "nombre" => "Rosa"
              "apellidos" => "Calvo Escalona"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1888989119300990"
        "doi" => "10.1016/j.rpsm.2019.10.004"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1888989119300990?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173505021000509?idApp=UINPBA00004N"
    "url" => "/21735050/0000001400000004/v1_202112011640/S2173505021000509/v1_202112011640/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Brief report</span>"
    "titulo" => "The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "212"
        "paginaFinal" => "217"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Victor Augusto Rodovalho Fava, Luciana Maria Sarin, Ana Cec&#237;lia Lucchese, Lorena Del Sant, Eduardo Magalh&#227;es, Rodrigo Simonini Delfino, Marco Aur&#233;lio Tuena, Carolina Nakahira, Andrea Parolin Jackowski, Guilherme Abdo, Juliana Surjan, Matheus Steiglich, Matheus Ghossain Barbosa, Jos&#233; Alberto Del Porto, Acioly Luiz Tavares Lacerda, Hugo Cogo-Moreira"
        "autores" => array:16 [
          0 => array:3 [
            "nombre" => "Victor Augusto Rodovalho"
            "apellidos" => "Fava"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Luciana Maria"
            "apellidos" => "Sarin"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Ana Cec&#237;lia"
            "apellidos" => "Lucchese"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Lorena"
            "apellidos" => "Del Sant"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Eduardo"
            "apellidos" => "Magalh&#227;es"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Rodrigo Simonini"
            "apellidos" => "Delfino"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Marco Aur&#233;lio"
            "apellidos" => "Tuena"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Carolina"
            "apellidos" => "Nakahira"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "Andrea Parolin"
            "apellidos" => "Jackowski"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "Guilherme"
            "apellidos" => "Abdo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "Juliana"
            "apellidos" => "Surjan"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          11 => array:3 [
            "nombre" => "Matheus"
            "apellidos" => "Steiglich"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          12 => array:3 [
            "nombre" => "Matheus Ghossain"
            "apellidos" => "Barbosa"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          13 => array:3 [
            "nombre" => "Jos&#233; Alberto Del"
            "apellidos" => "Porto"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          14 => array:3 [
            "nombre" => "Acioly Luiz Tavares"
            "apellidos" => "Lacerda"
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "fn0005"
              ]
            ]
          ]
          15 => array:4 [
            "nombre" => "Hugo"
            "apellidos" => "Cogo-Moreira"
            "email" => array:1 [
              0 => "hugocogo@hku.hk"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "fn0005"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "Department of Psychiatry&#44; Federal University of Sao Paulo&#44; Sao Paulo&#44; Brazil"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Centro Alfa de Humaniza&#231;&#227;o&#44; Escola Paulista de Medicina&#44; Federal University of Sao Paulo&#44; Sao Paulo&#44; Brazil"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "PRODAF &#8211; Programa de Transtornos Afetivos&#44; Department of Psychiatry&#44; Federal University of Sao Paulo&#44; Sao Paulo&#44; Brazil"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "LiNC &#8211; Laboratory of Integrative Neuroscience&#44; Department of Psychiatry&#44; Federal University of Sao Paulo&#44; Sao Paulo&#44; Brazil"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "School of Public Health&#44; University of Hong Kong&#44; Hong Kong&#44; SAR&#44; China"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Probabilidad de respuesta tras cada inyecci&#243;n subcut&#225;nea de esketamina en la depresi&#243;n resistente al tratamiento"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 800
            "Ancho" => 1667
            "Tamanyo" => 49889
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Hidden Markov model &#40;HMM&#41;&#58; observed variables and their corresponding latent class variables as they transition along the doses&#46; The HMM generated a latent class variable for each time point after doses 1&#8211;4 &#40;lat1&#44; lat2&#44; lat3&#44; and lat4&#41;&#46; Each latent class variable captured the unobserved features that were present at their respective time point and are correlated with the observed variable at that time point &#40;obs1&#44; obs2&#44; obs3&#44; and obs4&#41;&#46; An observed variable and its corresponding latent class variable were either a &#8220;responder&#8221; or a &#8220;non-responder&#8221;&#46; Each latent class variable transitioned into a subsequent one after the respective esketamine dose administration &#40;e&#46;g&#46;&#44; lat1 transitioned into lat2 after dose 1&#41;&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The treatment of patients with bipolar depression or major depressive disorder may be very challenging&#44; as pharmacological interventions are ineffective in a significant portion of cases&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">1</span></a> Patients who do not achieve remission after two or more treatments with an adequate dose of antidepressant for an adequate duration are considered to have treatment-resistant depression &#40;TRD&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">2</span></a> Ketamine and esketamine have been shown to have a robust antidepressant effect in such cases and have been considered to be a breakthrough in this context&#46;<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">3&#8211;5</span></a> To date&#44; there are no clinical practice guidelines recommending the use of ketamine or esketamine for depressive disorders&#46;<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Ketamine is an N-methyl-<span class="elsevierStyleSmallCaps">d</span>-aspartate &#40;NMDA&#41; receptor antagonist&#46; Its antidepressant activity is attributed to several mechanisms that converge into the generation of synaptic plasticity and potentiating of excitatory neurotransmission&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">6</span></a> Most hypotheses consider the blockage of NMDA receptors to be essential to the antidepressant effect&#44; but there is also research showing that ketamine&#39;s metabolites may independently exert it&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">7</span></a> At the cellular level&#44; ketamine leads to the activation of post synaptic &#945;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors &#40;AMPARs&#41;&#44; that triggers intracellular brain-derived neurotrophic factor &#40;BDNF&#41; release and the subsequent activation of the mechanistic target of rapamycin complex 1 &#40;mTORC1&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">8</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Ketamine is a racemate&#44; comprising the S-&#40;1&#41;-ketamine enantiomer &#40;esketamine&#41; and the R-&#40;2&#41;-ketamine enantiomer &#40;arketamine&#41;&#46; It has been demonstrated that esketamine is non-inferior compared to ketamine for patients with TRD&#46;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">9</span></a> Esketamine has also been related to a better safety profile&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">10</span></a> It can be administrated through several routes&#44; as following&#58; oral&#44; subcutaneous &#40;SC&#41;&#44; intranasal&#44; intramuscular&#44; intravenous &#40;IV&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> Data with respect to SC administration of esketamine are limited&#46;<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> Although&#44; it has been found that SC route appears to be more affordable and to have fewer collateral effects than the IV route&#44; while showing comparable efficacy in the treatment of TRD&#46;<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The administration of multiple doses of esketamine has shown efficacy for TRD&#44; as demonstrated by a large number of published phase 2 and phase 3 studies&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">10&#44;14&#8211;17</span></a> Nevertheless&#44; these trials did not provide a clear idea regarding the probability that a &#8220;non-responder&#8221; will become a &#8220;responder&#8221; &#40;and vice-versa&#41; after each esketamine infusion&#46; Generally&#44; they reported an average odds ratio&#44; calculated based on a longitudinal design and not on the individual transitions&#46; Understanding the individual transitions should help us answer the following critical questions&#58; if a patient is a &#8220;responder&#8221; to esketamine injection&#44; what is the probability of maintaining the same response status after the second injection&#63; Similarly&#44; if a patient is a &#8220;non-responder&#8221; at first&#44; what is the probability of becoming a &#8220;responder&#8221; after a subsequent dose&#63; In the case of multiple esketamine injections&#44; being a &#8220;responder&#8221; may impact the response status of the subsequent injection&#46; Hidden Markov model &#40;HMM&#41; is applicable to the case of multiple esketamine injections as it calculates the probability of changing from one response status to another&#44; while considering the previous status with each transition&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">The current naturalistic cohort study examines the probability of transitioning from being a &#8220;non-responder&#8221; to becoming a &#8220;responder&#8221; after each SC administration of esketamine&#44; following four injections from a series of six in 70 patients with TRD&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Participants and procedures</span><p id="par0030" class="elsevierStylePara elsevierViewall">The data in this study originated from a retrospective analysis of a case series of 70 patients with TRD&#44; who were referred by their treating psychiatrist to the esketamine clinic at the Department of Psychiatry of the Federal University of S&#227;o Paulo&#44; between April 2017 and December 2018&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Patients signed and dated a written informed consent document&#44; in support of their participation in the study&#44; and were aware they were not participating in a research protocol&#44; but in an academic assistance program&#46; The study was approved by the Federal University of S&#227;o Paulo Ethics Committee &#40;No&#46; 434&#47;2018&#41;&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Inclusion criteria were as follows&#58; current diagnosis of either major depressive disorder or bipolar depression according to DSM-IV as assessed with the Mini-International Neuropsychiatric Interview-Plus &#40;MINI-Plus&#41; 5&#46;0&#59; prior history of non-response to at least two antidepressants or approved drugs for bipolar depression&#44; used in an effective dose for at least 6 weeks&#59; Montgomery-&#197;sberg Depression Rating Scale &#40;MADRS&#41; score of &#8805;25&#59; age of 15 years or more&#46; Exclusion criteria were as follows&#58; history of hypersensitivity and&#47;or allergy to ketamine&#47;esketamine&#59; diagnosis of ketamine&#47;esketamine abuse or dependence&#59; uncontrolled hypertension&#59; pregnancy&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Participants were kept on stable doses of medications during the esketamine treatment&#46; Each participant received up to six weekly SC injections of esketamine in the abdomen&#44; at a dose of 0&#46;5&#8211;1&#46;0<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#46; A response was defined as at least 50&#37; decrease from baseline in the MADRS total score&#44; 24<span class="elsevierStyleHsp" style=""></span>h after dose administration&#46;<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> This definition was used to describe the patients as &#8220;responder&#8221; and &#8220;non-responder&#8221;&#46; Patients&#44; who did not become a &#8220;responder&#8221; within 24<span class="elsevierStyleHsp" style=""></span>h of receiving a dose&#44; received an increase of 0&#46;25<span class="elsevierStyleHsp" style=""></span>mg&#47;kg in the subsequent dose&#44; up to 1&#46;0<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Statistical analysis</span><p id="par0050" class="elsevierStylePara elsevierViewall">We used HMM to analyze the probability of a patient to become a &#8220;responder&#8221; or &#8220;non-responder&#8221; throughout four esketamine doses&#46; This method permits the analysis of a system whose actual state is not yet known&#44; but will be randomly originated from a certain future event&#46;<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> In this study&#44; esketamine injection was the event and it generated two possible observed outcomes&#58; &#8220;responder&#8221; and &#8220;non-responder&#8221;&#46; As a latent transition analysis&#44; HMM can describe the underlying population behavior based on a set of observed variables&#46; It identifies latent class variables&#44; which construct common patterns and behaviors from the whole population at the time of each of observation&#46; HMM analyzes the way individuals transition longitudinally from one latent class to another&#44;<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> as illustrated in <a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">Using Mplus 8 software&#44;<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">21</span></a> two HMMs were constructed&#46; In one model&#44; the transition matrices &#40;latent state intercepts and autoregressive paths&#41; were kept equal across the doses &#40;Model 1&#41;&#46; The other model had no constraints &#40;Model 2&#41;&#46; To calculate the difference in fit between the two models and to determine which model is more representative of the data&#44; we applied scaled loglikelihood-ratio tests&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Additionally&#44; we evaluated whether having major depressive disorder rather than bipolar depression would impact the latent response status across the doses of esketamine&#46; Considering the reduced sample size and the number of parameters to estimate &#40;one for each wave of assessment under HMM&#41;&#44; the following constraints were imposed&#58; we assumed that the probability of being &#8220;responder&#8221; and &#8220;non-responder&#8221; in every wave of assessment would be constant between both groups &#40;i&#46;e&#46;&#44; having major depressive disorder rather than bipolar depression&#41;&#46; Therefore&#44; the hypothesis underlying these constraints is that having major depressive disorder would cause the same impact across the four injections&#44; in terms of modifying the probability of response&#46;</p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Results</span><p id="par0065" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> shows the demographic and the clinical characteristics of the total cohort&#46; This naturalistic cohort is representative of patients with TRD who are referred to off-label esketamine treatment&#46; Most patients had severe TRD &#40;mean Madsley Staging Method total score &#62;11&#41; and 81&#46;42&#37; of them had at least one clinical comorbidity&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a> illustrates the number of patients that received each dose of esketamine and the corresponding number of patients that were evaluated 24<span class="elsevierStyleHsp" style=""></span>h after that dose&#46; We observed that after dose 1&#44; the proportion of patients responding to esketamine was 37&#46;70&#37;&#46; After dose 4&#44; it was 62&#46;50&#37;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">The constrained HMM &#40;model 1&#41; was more representative of the observed data than model 2 &#40;freed HMM&#41;&#58; Log likelihood&#58; &#8722;137&#46;84&#59; test<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">&#967;</span><span class="elsevierStyleSup">2</span> &#40;df&#41; <span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span> 3&#46;04&#44; <span class="elsevierStyleItalic">p</span>-value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#46;00&#46; In model 1&#44; a total of 16 patterns of the latent class variables were found across the doses&#46; The most frequent patterns were&#58; &#40;a&#41; &#8220;non-responder&#8221; across the four time points &#40;46&#46;44&#37;&#41;&#44; defined as &#8220;always non-responder&#8221; and &#40;b&#41; &#8220;responder&#8221; across the four time points &#40;15&#46;32&#37;&#41;&#44; defined as &#8220;always responder&#8221;&#46; Other prevalent latent patterns were&#58; non-responder-responder-responder-responder &#40;12&#46;85&#37;&#41;&#59; non-responder-non-responder-responder-responder &#40;11&#46;18&#37;&#41; and non-responder-non-responder-non-responder-responder &#40;9&#46;72&#37;&#41;&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">According to model 1&#44; the probability of a patient that was a &#8220;non-responder&#8221; after dose 1 to become a &#8220;responder&#8221; following dose 2 was 17&#46;30&#37;&#44; and the probability that this patient remains a &#8220;non-responder&#8221; following dose 2 was 82&#46;70&#37;&#46; The probability of a patient that was a &#8220;responder&#8221; after dose 1 remains a &#8220;responder&#8221; following dose 2 was 95&#37;&#44; whereas the probability that this patient will move back to &#8220;non-responder&#8221; was 5&#37;&#46; Since model 1 has equal transitioning matrices&#44; the same probabilities were obtained across the other doses&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">We tested the hypothesis that patients with major depressive disorder would have a different probability of response across the doses when compared to bipolar depressive patients&#46; Lack of evidence was found that unipolar depression would predict more responders &#40;odds ratio<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;57&#44; <span class="elsevierStyleItalic">p</span>-value<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;18&#41;&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Discussion</span><p id="par0090" class="elsevierStylePara elsevierViewall">To our knowledge&#44; this is the first study that used HMM to estimate the real-world probability that TRD patients respond throughout multiple SC esketamine injections&#46; As estimated by the best-fitted model&#44; the patterns of &#8220;always non-responder&#8221; and &#8220;always responder&#8221; were the most frequent latent behaviors across the four doses&#59; however&#44; the &#8220;always non-responder&#8221; pattern was three times more frequent than the &#8220;always responder&#8221; pattern&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">The model also found that the probability of being a &#8220;stayer&#8221; &#40;maintaining the same latent response status of either &#8220;responder&#8221; or &#8220;non-responder&#8221;&#41; from one injection to the subsequent one was higher than the probability of being of a &#8220;mover&#8221; &#40;transitioning to a different latent status at any point&#41;&#46; Accordingly&#44; it appears to be more likely to maintain the latent status &#8220;responder&#8221; than to become a &#8220;responder&#8221;&#46; Yet&#44; the probability of moving from a &#8220;non-responder&#8221; to a &#8220;responder&#8221; after a dose was 17&#46;30&#37;&#46; This probability is conditioned by the latent status obtained at the time before and&#44; by constraints of the model&#44; is held equal across the other time points&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">Intranasal esketamine has been approved for the treatment of TRD&#44; in conjunction with oral antidepressants&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">22</span></a> Even though the current study explored the SC route of administration&#44; it provides information about repeated doses of esketamine in the clinical practice&#46; We found no distinction in the probability of response to esketamine between unipolar and bipolar patients across the doses&#46; On the contrary&#44; a meta-analysis has shown that ketamine&#39;s antidepressant effect may extend over a longer period in the case of major depressive disorder compared to bipolar depression&#46;<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">23</span></a> Nevertheless&#44; the study considered only trials with a single ketamine infusion&#46; In clinical trials with multiple doses of ketamine&#44; the number of patients who achieve response appears to increase in the case of unipolar depression<a class="elsevierStyleCrossRefs" href="#bib0250"><span class="elsevierStyleSup">24&#44;25</span></a> and also in the case of bipolar depression&#46;<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">26</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Our findings should be looked at with caution because the study has some limitations&#46; The absence of a control group and randomization&#44; which are inherent to a real-world analysis&#44; limits the internal validity of the study&#46; Patients came from the same academic site&#44; and the number of patients enrolled in the study was somewhat limited&#46; In addition&#44; some of the patients missed one or more evaluations&#44; which is common in a real-world study&#46; The number of patients has also limited the analysis of whether having major depression disorder would be a modifier of the probability of response to esketamine compared to having bipolar depression&#46; Moreover&#44; participants kept their existing psychotropic medications during the esketamine treatment&#44; which may have influenced the results&#46; Furthermore&#44; we did not consider the increase in the esketamine dose as a variable and the response was evaluated over a short period of time&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">In conclusion&#44; our results provide details about the transition dynamics of response to multiple SC doses of esketamine in the treatment of TRD&#46; Considering four SC esketamine injections&#44; a patient with TRD&#44; who had been &#8220;non-responder&#8221; after a dose&#44; still had a chance &#40;17&#46;30&#37;&#41; to become a &#8220;responder&#8221; following the subsequent dose&#46; Additional research with a larger sample size a randomized placebo-controlled design is needed to further evaluate the response to multiple doses of esketamine administered through the SC route&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Funding</span><p id="par0115" class="elsevierStylePara elsevierViewall">This work was supported in part by the <span class="elsevierStyleGrantSponsor" id="gs1">Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior &#8211; Brasil &#40;CAPES&#41;</span> &#8211; Finance Code 001&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Conflict of interest</span><p id="par0120" class="elsevierStylePara elsevierViewall">The authors declare the following potential conflicts of interest&#58;</p><p id="par0125" class="elsevierStylePara elsevierViewall">Dr&#46; Sarin reports personal fees from Daiichi Sankyo Brasil&#44; Lundbeck Brasil&#44; Pfizer&#44; and Janssen and non-financial support from Takeda Brasil&#44; Moksha8 Brasil&#44; and Torrent Pharma&#44; outside the submitted work&#46; Dr&#46; Magalh&#227;es reports non-financial support from Torrent Pharma and Hypera Pharma&#44; outside the submitted work&#46; Dr&#46; Nakahira reports non-financial support from Eurofarma&#44; Crist&#225;lia&#44; and Sanofi&#44; outside the submitted work&#46; Dr&#46; Lacerda has received consulting fees from Janssen Pharmaceutical&#44; Daiichi Sankyo Brasil&#44; Cristalia Produtos Qu&#237;micos e Farmac&#234;uticos&#44; Pfizer&#44; Mantecorp Ind&#250;stria Qu&#237;mica e Farmac&#234;utica&#44; Libbs Farmac&#234;utica&#44; and Sanofi-Aventis over the last 24 months and has received research fees from Janssen Pharmaceutical&#44; Eli Lilly&#44; H&#46; Lundbeck A&#47;S&#44; Servier Laboratories&#44; Hoffman-La Roche&#44; and Forum Pharmaceuticals&#44; not related to the submitted manuscript&#46; None of the remaining authors have any potential conflicts to disclose&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:3 [
          "identificador" => "xres1619145"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Introduction"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Material and methods"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1446174"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1619146"
          "titulo" => "Resumen"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Introducci&#243;n"
            ]
            1 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Material y m&#233;todos"
            ]
            2 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Resultados"
            ]
            3 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1446175"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Material and methods"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Participants and procedures"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Statistical analysis"
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Results"
        ]
        7 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Discussion"
        ]
        8 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Funding"
        ]
        9 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflict of interest"
        ]
        10 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-06-17"
    "fechaAceptado" => "2020-10-05"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1446174"
          "palabras" => array:5 [
            0 => "Esketamine"
            1 => "Latent transition analysis"
            2 => "Treatment-resistant depression"
            3 => "Bipolar depression"
            4 => "Treatment response"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1446175"
          "palabras" => array:5 [
            0 => "Esketamina"
            1 => "An&#225;lisis de transici&#243;n latente"
            2 => "Depresi&#243;n resistente al tratamiento"
            3 => "Depresi&#243;n bipolar"
            4 => "Respuesta al tratamiento"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The administration of multiple esketamine doses has shown efficacy for unipolar and bipolar treatment-resistant depression &#40;TRD&#41;&#46; Nevertheless&#44; the probability of responding or not after each dose in the real-world remains unknown&#46; This study aimed to estimate it throughout four doses of esketamine&#44; administrated via subcutaneous &#40;SC&#41;&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Material and methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We conducted a retrospective analysis of a case series of 70 patients with TRD who received treatment from the esketamine assistance program at Federal University of Sao Paulo&#44; between April 2017 and December 2018&#46; The SC injections were administrated weekly at a dose of 0&#46;5&#8211;1&#46;0<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#44; in conjunction with patients&#8217; psychotropic drugs&#46; Response was defined as a decrease of at least 50&#37; in the Montgomery-&#197;sberg Depression Rating Scale between baseline and 24<span class="elsevierStyleHsp" style=""></span>h after dose&#46; We used hidden Markov modeling in order to estimate de probability of response after each esketamine injection&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The probability of a patient that was a &#8220;non-responder&#8221; to become a &#8220;responder&#8221; following a SC injection of esketamine was 17&#46;30&#37; and the probability that this patient remains a &#8220;non-responder&#8221; was 82&#46;70&#37;&#46; The probability of a patient that was a &#8220;responder&#8221; to remain as a &#8220;responder&#8221; was 95&#37;&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Patients with TRD who had not responded after the first dose of esketamine&#44; still had a chance of responding after the subsequent dose administrated via SC&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Introduction"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Material and methods"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introducci&#243;n</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La administraci&#243;n de dosis m&#250;ltiples de esketamina ha demostrado su eficacia para el tratamiento de la depresi&#243;n unipolar y bipolar resistente al tratamiento &#40;TRD&#41;&#46; Sin embargo&#44; sigue siendo una inc&#243;gnita la probabilidad de responder o no tras cada dosis en el mundo real&#46; El objetivo de este estudio fue calcular dicha probabilidad durante la administraci&#243;n v&#237;a subcut&#225;nea &#40;SC&#41; de cuatro dosis de esketamina&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Material y m&#233;todos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Realizamos un an&#225;lisis retrospectivo de una serie de casos de 70 pacientes con TRD&#44; que recibieron tratamiento a trav&#233;s del programa de asistencia con esketamina en la Universidad Federal University de Sao Paulo&#44; entre abril de 2017 y diciembre de 2018&#46; Las inyecciones SC se administraron semanalmente&#44; a dosis de 0&#44;5-1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#44; junto con los medicamentos psicotr&#243;picos de los pacientes&#46; Se defini&#243; la respuesta como una reducci&#243;n de al menos el 50&#37; en la Escala de Calificaci&#243;n de la Depresi&#243;n de Montgomery-&#197;sberg entre el valor basal y las 24 horas posteriores a la administraci&#243;n de la dosis&#46; Utilizamos el modelo oculto de Markov para calcular la probabilidad de respuesta tras cada inyecci&#243;n de esketamina&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">La probabilidad de que un paciente que fuera &#171;no respondedor&#187; se convirtiera en &#171;respondedor&#187;&#44; tras una inyecci&#243;n SC de esketamina fue del 17&#44;3&#37;&#44; y la probabilidad de que este paciente siguiera siendo &#171;no respondedor&#187; fue del 82&#44;7&#37;&#46; La probabilidad de que un paciente que fuera &#171;respondedor&#187; lo siguiera siendo fue del 95&#37;&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Los pacientes con TRD que no han respondido a la primera dosis de esketamina&#44; tienen probabilidad de respuesta tras la administraci&#243;n de las siguientes dosis por v&#237;a SC&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Introducci&#243;n"
          ]
          1 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Material y m&#233;todos"
          ]
          2 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:3 [
        "etiqueta" => "1"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Acioly L&#46;T&#46; Lacerda and Hugo Cogo-Moreira should be considered joint senior authors&#46;</p>"
        "identificador" => "fn0005"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 800
            "Ancho" => 1667
            "Tamanyo" => 49889
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Hidden Markov model &#40;HMM&#41;&#58; observed variables and their corresponding latent class variables as they transition along the doses&#46; The HMM generated a latent class variable for each time point after doses 1&#8211;4 &#40;lat1&#44; lat2&#44; lat3&#44; and lat4&#41;&#46; Each latent class variable captured the unobserved features that were present at their respective time point and are correlated with the observed variable at that time point &#40;obs1&#44; obs2&#44; obs3&#44; and obs4&#41;&#46; An observed variable and its corresponding latent class variable were either a &#8220;responder&#8221; or a &#8220;non-responder&#8221;&#46; Each latent class variable transitioned into a subsequent one after the respective esketamine dose administration &#40;e&#46;g&#46;&#44; lat1 transitioned into lat2 after dose 1&#41;&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 380
            "Ancho" => 2500
            "Tamanyo" => 80966
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">The number of patients receiving doses 1&#8211;4 and the number of evaluated patients 24<span class="elsevierStyleHsp" style=""></span>h after the respective dose&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">SD&#58; standard deviation&#59; MDD&#58; Major Depressive Disorder&#59; BD&#58; Bipolar Disorder&#59; MADRS&#58; Montgomery&#8211;&#197;sberg Depression Rating Scale&#59; MSM&#58; Maudsley Staging Method&#59; BMI&#58; Body Mass Index&#46; <span class="elsevierStyleItalic">n</span>&#59; &#37;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Variables&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Value&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Age &#40;years&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40&#46;31<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> &#40;SD<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>12&#46;623&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Sex</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Male&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">25 &#40;35&#46;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Female&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">45 &#40;64&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Education</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>College graduate&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">42 &#40;60&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Incomplete college graduation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12 &#40;17&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>8&#8211;11 years of education&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">14 &#40;20&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>5&#8211;8 years of education&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;2&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Occupational status</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Employed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16 &#40;22&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Unemployed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">13 &#40;18&#46;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Medical leave&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22 &#40;31&#46;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Retired&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7 &#40;10&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Student&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9 &#40;12&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Informal worker&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;4&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Diagnosis</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>MDD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">39 &#40;55&#46;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>BD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31 &#40;44&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Baseline</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>MADRS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33&#46;6<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> &#40;SD<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>6&#46;321&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>MSM&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11&#46;09<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> &#40;SD<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>2&#46;034&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Anxiety disorder&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31 &#40;44&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Prior psychiatric hospitalization&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">29 &#40;41&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Prior suicide history&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">29 &#40;41&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>BMI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">29&#46;1<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> &#40;SD<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>7&#46;456&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Obesity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">25 &#40;35&#46;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Hypertension&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12 &#40;17&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2759137.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Mean value&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Patient demographics and clinical characteristics&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:26 [
            0 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacological approaches to the challenge of treatment-resistant depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "D&#46;F&#46; Ionescu"
                            1 => "J&#46;F&#46; Rosenbaum"
                            2 => "J&#46;E&#46; Alpert"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Dialog Clin Neurosci"
                        "fecha" => "2015"
                        "volumen" => "17"
                        "paginaInicial" => "111"
                        "paginaFinal" => "126"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment-resistant depression&#58; definitions&#44; review of the evidence&#44; and algorithmic approach"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;S&#46; McIntyre"
                            1 => "M&#46;J&#46; Filteau"
                            2 => "L&#46; Martin"
                            3 => "S&#46; Patry"
                            4 => "A&#46; Carvalho"
                            5 => "D&#46;S&#46; Cha"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jad.2013.10.043"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Affect Disord"
                        "fecha" => "2014"
                        "volumen" => "156"
                        "paginaInicial" => "1"
                        "paginaFinal" => "7"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24314926"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ketamine and beyond&#58; investigations into the potential of glutamatergic agents to treat depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;S&#46; Lener"
                            1 => "B&#46; Kadriu"
                            2 => "C&#46;A&#46; Zarate"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s40265-017-0702-8"
                      "Revista" => array:6 [
                        "tituloSerie" => "Drugs"
                        "fecha" => "2017"
                        "volumen" => "77"
                        "paginaInicial" => "381"
                        "paginaFinal" => "401"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28194724"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Off-label use of ketamine for treatment-resistant depression in clinical practice&#58; European perspective"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "&#193;&#46; L&#243;pez-D&#237;az"
                            1 => "M&#46; Murillo-Izquierdo"
                            2 => "E&#46; Moreno-Mellado"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1192/bjp.2019.102"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Psychiatry"
                        "fecha" => "2019"
                        "volumen" => "215"
                        "paginaInicial" => "447"
                        "paginaFinal" => "448"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31030677"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Eficacia y seguridad de la ketamina en depresi&#243;n bipolar&#58; una revisi&#243;n sistem&#225;tica"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Alberich"
                            1 => "M&#46; Mart&#237;nez-Cengotitabengoa"
                            2 => "P&#46; L&#243;pez"
                            3 => "I&#46; Zorrilla"
                            4 => "N&#46; N&#250;&#241;ez"
                            5 => "E&#46; Vieta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.rpsm.2016.05.005"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Psiquiatr Salud Ment"
                        "fecha" => "2017"
                        "volumen" => "10"
                        "paginaInicial" => "104"
                        "paginaFinal" => "112"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27387226"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanisms of ketamine action as an antidepressant"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46; Zanos"
                            1 => "T&#46;D&#46; Gould"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/mp.2017.255"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mol Psychiatry"
                        "fecha" => "2018"
                        "volumen" => "23"
                        "paginaInicial" => "801"
                        "paginaFinal" => "811"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29532791"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "NMDAR inhibition-independent antidepressant actions of ketamine metabolites"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Zanos"
                            1 => "R&#46; Moaddel"
                            2 => "P&#46;J&#46; Morris"
                            3 => "P&#46; Georgiou"
                            4 => "J&#46; Fischell"
                            5 => "G&#46;I&#46; Elmer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Nature"
                        "fecha" => "2016"
                        "volumen" => "533"
                        "paginaInicial" => "481"
                        "paginaFinal" => "486"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46; Zhou"
                            1 => "N&#46; Wang"
                            2 => "C&#46; Yang"
                            3 => "X&#46;M&#46; Li"
                            4 => "Z&#46;Q&#46; Zhou"
                            5 => "J&#46;J&#46; Yang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.eurpsy.2013.10.005"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Psychiatry"
                        "fecha" => "2014"
                        "volumen" => "29"
                        "paginaInicial" => "419"
                        "paginaFinal" => "423"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24321772"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression&#58; a randomized&#44; double-blind&#44; non-inferiority study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46;S&#46; Correia-Melo"
                            1 => "G&#46;C&#46; Leal"
                            2 => "F&#46; Vieira"
                            3 => "A&#46;P&#46; Jesus-Nunes"
                            4 => "R&#46;P&#46; Mello"
                            5 => "G&#46; Magnavita"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jad.2019.11.086"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Affect Disord"
                        "fecha" => "2020"
                        "volumen" => "264"
                        "paginaInicial" => "527"
                        "paginaFinal" => "534"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31786030"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression&#58; a randomized double-blind active-controlled study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; Popova"
                            1 => "E&#46;J&#46; Daly"
                            2 => "M&#46; Trivedi"
                            3 => "K&#46; Cooper"
                            4 => "R&#46; Lane"
                            5 => "P&#46; Lim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Psychiatry"
                        "fecha" => "2019"
                        "volumen" => "176"
                        "paginaInicial" => "428"
                        "paginaFinal" => "438"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Administration of ketamine for unipolar and bipolar depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Kraus"
                            1 => "U&#46; Rabl"
                            2 => "T&#46; Vanicek"
                            3 => "L&#46; Carlberg"
                            4 => "A&#46; Popovic"
                            5 => "M&#46; Spies"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Int J Psychiatry Clin Pract"
                        "fecha" => "2017"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A consensus statement on the use of ketamine in the treatment of mood disorders"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Sanacora"
                            1 => "M&#46;A&#46; Frye"
                            2 => "W&#46; McDonald"
                            3 => "S&#46;J&#46; Mathew"
                            4 => "M&#46;S&#46; Turner"
                            5 => "A&#46;F&#46; Schatzberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamapsychiatry.2017.0080"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Psychiatry"
                        "fecha" => "2017"
                        "volumen" => "74"
                        "paginaInicial" => "399"
                        "paginaFinal" => "405"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28249076"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Placebo-controlled pilot trial testing dose titration and intravenous&#44; intramuscular and subcutaneous routes for ketamine in depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;K&#46; Loo"
                            1 => "V&#46; G&#225;lvez"
                            2 => "E&#46; O&#8217;Keefe"
                            3 => "P&#46;B&#46; Mitchell"
                            4 => "D&#46; Hadzi-Pavlovic"
                            5 => "J&#46; Leyden"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/acps.12572"
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Psychiatr Scand"
                        "fecha" => "2016"
                        "volumen" => "134"
                        "paginaInicial" => "48"
                        "paginaFinal" => "56"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27028832"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intravenous esketamine in adult treatment-resistant depression&#58; a double-blind&#44; double-randomization&#44; placebo-controlled study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;B&#46; Singh"
                            1 => "M&#46; Fedgchin"
                            2 => "E&#46; Daly"
                            3 => "L&#46; Xi"
                            4 => "C&#46; Melman"
                            5 => "G&#46; De Bruecker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.biopsych.2015.10.018"
                      "Revista" => array:6 [
                        "tituloSerie" => "Biol Psychiatry"
                        "fecha" => "2016"
                        "volumen" => "80"
                        "paginaInicial" => "424"
                        "paginaFinal" => "431"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26707087"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide&#58; results of a double-blind&#44; randomized&#44; placebo-controlled study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;M&#46; Canuso"
                            1 => "J&#46;B&#46; Singh"
                            2 => "M&#46; Fedgchin"
                            3 => "L&#46; Alphs"
                            4 => "R&#46; Lane"
                            5 => "P&#46; Lim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1176/appi.ajp.2018.17060720"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Psychiatry"
                        "fecha" => "2018"
                        "volumen" => "175"
                        "paginaInicial" => "620"
                        "paginaFinal" => "630"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29656663"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression&#58; a randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46;J&#46; Daly"
                            1 => "J&#46;B&#46; Singh"
                            2 => "M&#46; Fedgchin"
                            3 => "K&#46; Cooper"
                            4 => "P&#46; Lim"
                            5 => "R&#46;C&#46; Shelton"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamapsychiatry.2017.3739"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Psychiatry"
                        "fecha" => "2018"
                        "volumen" => "75"
                        "paginaInicial" => "139"
                        "paginaFinal" => "148"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29282469"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression&#58; a randomized clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46;J&#46; Daly"
                            1 => "M&#46;H&#46; Trivedi"
                            2 => "A&#46; Janik"
                            3 => "H&#46; Li"
                            4 => "Y&#46; Zhang"
                            5 => "X&#46; Li"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jamapsychiatry.2019.1189"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA Psychiatry"
                        "fecha" => "2019"
                        "volumen" => "76"
                        "paginaInicial" => "893"
                        "paginaFinal" => "903"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31166571"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Report by the ACNP Task Force on response and remission in major depressive disorder"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;J&#46; Rush"
                            1 => "H&#46;C&#46; Kraemer"
                            2 => "H&#46;A&#46; Sackeim"
                            3 => "M&#46; Fava"
                            4 => "M&#46;H&#46; Trivedi"
                            5 => "E&#46; Frank"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.npp.1301131"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neuropsychopharmacology"
                        "fecha" => "2006"
                        "volumen" => "31"
                        "paginaInicial" => "1841"
                        "paginaFinal" => "1853"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16794566"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "What is a hidden Markov model&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "S&#46;R&#46; Eddy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nbt1004-1315"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Biotechnol"
                        "fecha" => "2004"
                        "volumen" => "22"
                        "paginaInicial" => "1315"
                        "paginaFinal" => "1316"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15470472"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Latent class and latent transition analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;T&#46; Lanza"
                            1 => "B&#46;P&#46; Flaherty"
                            2 => "L&#46;M&#46; Collins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:1 [
                        "fecha" => "2003"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mplus user&#39;s guide"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46;K&#46; Muth&#233;n"
                            1 => "B&#46;O&#46; Muth&#233;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:2 [
                        "edicion" => "6th ed&#46;"
                        "fecha" => "2011"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Esketamine is approved in Europe for treating resistant major depressive disorder"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "E&#46; Mahase"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj.l6553"
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2019"
                        "volumen" => "367"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31748343"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Romeo"
                            1 => "W&#46; Choucha"
                            2 => "P&#46; Fossati"
                            3 => "J&#46;Y&#46; Rotge"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.psychres.2015.10.032"
                      "Revista" => array:6 [
                        "tituloSerie" => "Psychiatry Res"
                        "fecha" => "2015"
                        "volumen" => "230"
                        "paginaInicial" => "682"
                        "paginaFinal" => "688"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26548981"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;R&#46; Shiroma"
                            1 => "B&#46; Johns"
                            2 => "M&#46; Kuskowski"
                            3 => "J&#46; Wels"
                            4 => "P&#46; Thuras"
                            5 => "C&#46;S&#46; Albott"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jad.2013.10.036"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Affect Disord"
                        "fecha" => "2014"
                        "volumen" => "155"
                        "paginaInicial" => "123"
                        "paginaFinal" => "129"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24268616"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Single&#44; repeated&#44; and maintenance ketamine infusions for treatment-resistant depression&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;L&#46; Phillips"
                            1 => "S&#46; Norris"
                            2 => "J&#46; Talbot"
                            3 => "M&#46; Birmingham"
                            4 => "T&#46; Hatchard"
                            5 => "A&#46; Ortiz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1176/appi.ajp.2018.18070834"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Psychiatry"
                        "fecha" => "2019"
                        "volumen" => "176"
                        "paginaInicial" => "401"
                        "paginaFinal" => "409"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30922101"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46; Zheng"
                            1 => "Y&#46;L&#46; Zhou"
                            2 => "W&#46;J&#46; Liu"
                            3 => "C&#46;Y&#46; Wang"
                            4 => "Y&#46;N&#46; Zhan"
                            5 => "H&#46;Q&#46; Li"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jpsychires.2018.09.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Psychiatr Res"
                        "fecha" => "2018"
                        "volumen" => "106"
                        "paginaInicial" => "61"
                        "paginaFinal" => "68"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30278319"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735050/0000001400000004/v1_202112011640/S217350502100056X/v1_202112011640/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "7614"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735050/0000001400000004/v1_202112011640/S217350502100056X/v1_202112011640/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217350502100056X?idApp=UINPBA00004N"
]

Article information

ISSN: 21735050
Original language: English

DOI:10.1016/j.rpsmen.2021.11.003

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 October	3	5	8
2024 September	25	18	43
2024 August	24	20	44
2024 July	11	10	21
2024 June	6	7	13
2024 May	10	12	22
2024 April	24	15	39
2024 March	25	8	33
2024 February	16	12	28
2024 January	16	6	22
2023 December	12	7	19
2023 November	13	14	27
2023 October	26	15	41
2023 September	12	11	23
2023 August	10	7	17
2023 July	8	11	19
2023 June	11	5	16
2023 May	37	16	53
2023 April	48	14	62
2023 March	23	10	33
2023 February	22	7	29
2023 January	11	7	18
2022 December	14	8	22
2022 November	33	6	39
2022 October	17	10	27
2022 September	25	8	33
2022 August	17	6	23
2022 July	27	10	37
2022 June	19	6	25
2022 May	19	4	23
2022 April	37	10	47

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter